Jim Davis to Present Quest Diagnostics' Strategies at William Blair Conference

Quest Diagnostics to Present at the William Blair 45th Annual Growth Stock Conference

Quest Diagnostics Incorporated (NYSE: DGX), a prominent leader in diagnostic information services, has announced that its Chairman and CEO, Jim Davis, will deliver a presentation at the esteemed William Blair 45th Annual Growth Stock Conference. The event is scheduled to take place in Chicago on June 3, 2025, at 11:00 AM Eastern Time.

During his talk, Davis plans to elaborate on the company's strategic direction, its performance metrics, and the latest developments and emerging trends in the healthcare market. This is an opportunity for investors, analysts, and IT professionals in the medical field to gain insights into how Quest Diagnostics is positioning itself in an ever-evolving health landscape.

The presentation will be made available for live streaming on the company’s investor relations webpage. Interested individuals can access the stream at ir.QuestDiagnostics.com. Furthermore, an archived version of the webcast will be accessible within 24 hours following the live session and will remain online until July 3, 2025, for those who wish to revisit the key points discussed.

About Quest Diagnostics

Quest Diagnostics has a robust mission to enhance the healthcare ecosystem by providing critical diagnostic insights that empower healthcare providers and patients alike. With their vast database of de-identified clinical lab results, they consistently reveal innovative pathways to identify and manage diseases while promoting healthier lifestyle choices.

As one of the leading diagnostic providers in the United States, Quest Diagnostics serves approximately one in three adult Americans, making their diagnostic services integral to the healthcare of millions. With a workforce exceeding 55,000, the company underscores its commitment to improving health outcomes and transforming lives through their actionable insights.

Their strong portfolio of lab services not only supports physicians and hospitals but also enables improved healthcare management across various sectors. As the general public becomes increasingly aware of the importance of diagnostic testing in preventive healthcare, engagement with industry leaders like Quest will be pivotal in shaping future healthcare norms and methodologies.

In summary, Jim Davis’s appearance at the William Blair conference signifies Quest Diagnostics’ continuing leadership and innovation in the health sector, and provides a platform for dialogue on strategies that address existing and future healthcare challenges.

For more information on Quest Diagnostics, view their official website at www.QuestDiagnostics.com.